Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet the NGS Experts Series Part 3
Pancreatic cancer is a uniquely lethal malignancy characterized by frequent mutations in KRAS, CDKN2...
37 slides
3,350
Healthcare
QIAGENscience